Rachael Nokes - 31 Jan 2022 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
Title: SVP, Finance; Principal Accounting Officer
Signature
/s/ Rachael Nokes
Issuer symbol
SCPH
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
4
Filing time
01 Feb 2022, 16:30:04 UTC
Next filing
23 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPH Stock Option (Right to Buy) Award $0 +54,700 $0.000000 54,700 31 Jan 2022 Common Stock 54,700 $4.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest over a four-year period, at a rate of 25% on the first anniversary of the grant date, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares are fully vested on the fourth anniversary of the grant date.

Remarks:

Title: SVP, Finance; Principal Accounting Officer